Login / Signup

Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer.

Nobutaka TasakaTakeo MinaguchiYoshihiko HosokawaWataru TakaoHiroya ItagakiKeiko NishidaAzusa AkiyamaAyumi ShikamaHiroyuki OchiToyomi Satoh
Published in: The journal of obstetrics and gynaecology research (2020)
Pretreatment asymptomatic VTE is very frequent in gynecological cancer patients. It may be beneficial to consider measuring DD or performing venous ultrasonography in patients with the above risk factors.
Keyphrases